TrialCancer science2007

Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients.

Yuji Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.